173 related articles for article (PubMed ID: 35809100)
1. Cytotoxic lesions of the corpus callosum after COVID-19 vaccination.
Ohara H; Shimizu H; Kasamatsu T; Kajita A; Uno K; Lai KW; Vellingiri B; Sugie K; Kinoshita M
Neuroradiology; 2022 Oct; 64(10):2085-2089. PubMed ID: 35809100
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic lesion of corpus callosum after COVID-19 vaccination: case report.
Chang WL; Cheng CF; Lin SK
Acta Neurol Taiwan; 2024 Jun; 33(2)():68-72. PubMed ID: 37848228
[TBL] [Abstract][Full Text] [Related]
3. "Reversible cytotoxic lesion of the corpus callosum following SARS-CoV-2 mRNA vaccine administration: a finding to be aware of".
Procaccini L; Mincuzzi E; Bernardini A; Franchi P; Voicu IP; Caulo M
Neuroradiol J; 2022 Dec; 35(6):758-762. PubMed ID: 35488375
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor 5-related autoimmune encephalitis with reversible splenial lesion syndrome following SARS-CoV-2 vaccination.
Zhang Y; Lian B; Yang S; Huang X; Zhou Y; Cao L
Medicine (Baltimore); 2023 Feb; 102(7):e32971. PubMed ID: 36800591
[TBL] [Abstract][Full Text] [Related]
5. Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review.
Kubo M; Kubo K; Kobayashi KI; Komiya N
Int J Infect Dis; 2022 Dec; 125():1-9. PubMed ID: 36122669
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic lesions of the corpus callosum in children: Etiology, clinical and radiological features, and prognosis.
Aksu Uzunhan T; Maraş Genç H; Kutlubay B; Kalın S; Bektaş G; Yapıcı Ö; Çıracı S; Sözen HG; Şevketoğlu E; Palabıyık F; Gör Z; Çakar NE; Kara B
Brain Dev; 2021 Oct; 43(9):919-930. PubMed ID: 34120800
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic Lesion of the Corpus Callosum (CLOCCs) after SARS-CoV-2 mRNA Vaccination.
Youn T; Yang H
J Korean Med Sci; 2021 Aug; 36(31):e228. PubMed ID: 34402238
[No Abstract] [Full Text] [Related]
8. Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination.
Takanashi J; Shiihara T; Hasegawa T; Takayanagi M; Hara M; Okumura A; Mizuguchi M
J Neurol Sci; 2015 Feb; 349(1-2):226-8. PubMed ID: 25542078
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic Lesions of the Corpus Callosum (CLOCC) Suggesting Exacerbation by Heterogeneous COVID-19 Booster Vaccination.
Chiba Y; Takahashi Y; Kawakita R; Deguchi K; Masaki T
Cureus; 2023 Jun; 15(6):e41105. PubMed ID: 37519563
[TBL] [Abstract][Full Text] [Related]
10. Mild encephalitis/encephalopathy with a reversible splenial lesion associated with systemic Mycoplasma pneumoniae infection in North America: a case report.
Talukder NT; Feezel A; Lankford JE
J Med Case Rep; 2022 Feb; 16(1):74. PubMed ID: 35183255
[TBL] [Abstract][Full Text] [Related]
11. Mild encephalitis/encephalopathy with a reversible splenial lesion secondary to encephalitis complicated by hyponatremia: A case report and literature review.
Shi BC; Li J; Jiang JW; Li MX; Zhang J; Shang XL
Medicine (Baltimore); 2019 Nov; 98(47):e17982. PubMed ID: 31764808
[TBL] [Abstract][Full Text] [Related]
12. [Mild encephalitis/encephalopathy with a reversible splenial corpus callosum lesion (MERS)].
Moreno-Caballero L; Navas-Campo R; Bello-Franco CM; Sesé-Lacámara L; Sáez-Valero E; Gimeno-Peribáñez MJ
Rev Neurol; 2021 Sep; 73(6):219-222. PubMed ID: 34515335
[TBL] [Abstract][Full Text] [Related]
13. Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.
Zhu Y; Zheng J; Zhang L; Zeng Z; Zhu M; Li X; Lou X; Wan H; Hong D
BMC Neurol; 2016 Apr; 16():49. PubMed ID: 27089920
[TBL] [Abstract][Full Text] [Related]
14. Transient blindness associated with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS): a case report and review of literature.
Tuscano A; Zoppo M; Canavese C; Cogoni M; Scolfaro C
Ital J Pediatr; 2020 Oct; 46(1):152. PubMed ID: 33046117
[TBL] [Abstract][Full Text] [Related]
15. Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children.
Bektaş G; Akçay N; Boydağ K; Şevketoğlu E
Brain Dev; 2021 Feb; 43(2):230-233. PubMed ID: 33082059
[TBL] [Abstract][Full Text] [Related]
16. Reversible lesion in the splenium of the corpus callosum.
Tetsuka S
Brain Behav; 2019 Nov; 9(11):e01440. PubMed ID: 31588684
[TBL] [Abstract][Full Text] [Related]
17. Adult severe encephalitis/encephalopathy with a reversible splenial lesion of the corpus callosum: A case report.
Mao XJ; Zhu BC; Yu TM; Yao G
Medicine (Baltimore); 2018 Jun; 97(26):e11324. PubMed ID: 29953022
[TBL] [Abstract][Full Text] [Related]
18. [Clinically mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum in a child and literature review].
Zhao L; Wu Y; Guo M; Xiao J; Jiang Y
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):218-22. PubMed ID: 24824394
[TBL] [Abstract][Full Text] [Related]
19. A 23-Year-Old Man with SARS-CoV-2 Infection Who Presented with Auditory Hallucinations and Imaging Findings of Cytotoxic Lesions of the Corpus Callosum (CLOCC).
Elkhaled W; Ben Abid F; Akhtar N; Abukamar MR; Ibrahim WH
Am J Case Rep; 2020 Dec; 21():e928798. PubMed ID: 33315854
[TBL] [Abstract][Full Text] [Related]
20. Thyroid crisis mimicking clinically mild encephalitis/encephalopathy with a reversible splenial lesion: A pediatric case report.
Matsubara K; Kuki I; Yamamoto N; Nagase S; Inoue T; Nukui M; Okazaki S; Yamada Y; Kawawaki H
Brain Dev; 2021 Apr; 43(4):596-600. PubMed ID: 33408037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
